Use Hospira Inc. media headlines concurrently with your other holdings to enhance returns of your portfolios and to back test it against optimization strategy that fits your risk preferences.
My goal moving forward in a very volatile and uncertain economy is to invest in stocks that I believe to be value investments. So far in 2012, I have written several articles expressing my beliefs that the absolute best value in the market is in the ...
FiercePharma - May 16, 2012
Eloxatin managed to make the top 5 this time based on 2011, but 2012 may be another story. The drug goes off patent in August, and a slew of generics are already approved.
As per reports, it has been revealed that Hospira Inc. (HSP) has recalled one lot of Hydromorphone Hydrochloride Injection, as it contained more than desired opioid.
NASDAQ - May 15, 2012
(RTTNews.com) - Hospira Inc.(HSP) has initiated a nationwide voluntary recall of one lot of Hydromorphone Hydrochloride Injection 1 mg/ml, with the knowledge of the FDA, after it was found that the opioid analgesic injection contained more than the ...
By Mark Lawson Shares of Ventrus Biosciences (NASDAQ:VTUS) pop, subsequent to the announcement that Phase III trials of its Diltiazem treatment for the relief of pain associated with anal fissures showed significant improvements over placebos.
MarketWatch - May 14, 2012
By Jon Kamp Hospira Inc. (NYSE:HSP) has recalled one lot of pre-filled cartridges containing the generic pain drug hydromorphone because the glass cartridges could contain too much medicine.
By Jon Kamp Of DOW JONES NEWSWIRES Hospira Inc. (HSP) has recalled one lot of pre-filled cartridges containing the generic pain drug hydromorphone because the glass cartridges could contain too much medicine.
Hospira Inc (NYSE:HSP) is down 0.87% to $33.05. The Company has recalled one lot of pre-filled cartridges containing the pain drug hydromorphone because the glass cartridges could contain too much medicine.
MarketWatch - May 14, 2012
By Jon Kamp Hospira Inc. (NYSE:HSP) has recalled one lot of pre-filled cartridges containing the pain drug hydromorphone because the glass cartridges could contain too much medicine.
Hospira Recalls One Lot Of Opioid Analgesic Injection - RTT News
By Derek Hoffman Salesforce.com (NYSE:CRM): Deutsche Bank said its channel checks indicate Salesforce.com underwent a large restructuring within its sales organization, which the firm believes could impact the company's Q1 results.
Brevard Times - May 12, 2012
Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary user level recall of one lot of Hydromorphone Injection, USP, 1 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject?, NDC 0409-1283-31, due to two reported complaints of a single ...
Hospira Announces A Nationwide Voluntary Recall Of One Lot Of Hydromorphone ... - Pharmaceutical Processing
MedCity News - May 10, 2012
Propofol might best be known as the anesthetic Michael Jackson used inappropriately as a sleeping aid. Administered properly, the drug widely is used in hospitals to sedate patients.
Sacramento Bee - May 10, 2012
By Hospira, Inc. LAKE FOREST, Ill., May 9, 2012 -- /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today held its 2012 Annual Meeting of Shareholders in Arlington, Va.
Sacramento Bee - May 9, 2012
By Hospira, Inc. LAKE FOREST, Ill., May 8, 2012 -- /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will present at the following upcoming ...
Based on latest financial disclosure Hospira Inc. has Total Debt of 1.78 B. This is 41.73% higher than that of Healthcare sector, and 38.07% higher than that of Drug Delivery industry, The Total Debt for all stocks is 62.39% higher than the company.
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.